We are live on
!
Find out more
Skandinaviska Enskilda Banken (SEB) Portfolio holdings
AUM
$4.34B
1-Year Est. Return
19.31%
This Quarter
Est. Return
+5.84%
1 Year Est. Return
+19.31%
3 Year Est. Return
+90.68%
5 Year Est. Return
+128.22%
10 Year Est. Return
+495.11%
AUM
$11B
AUM Growth
+$640M
(+6.1%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
767
New
23
Increased
358
Reduced
116
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$263M |
| 2 |
AT&T
T
|
+$112M |
| 3 |
CA
CA, Inc.
CA
|
+$87.9M |
| 4 |
CenterPoint Energy
CNP
|
+$74.4M |
| 5 |
GAP
The Gap Inc
GAP
|
+$48.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$159M |
| 2 |
Southwest Airlines
LUV
|
+$99M |
| 3 |
Magna International
MGA
|
+$63.8M |
| 4 |
Parker-Hannifin
PH
|
+$60.2M |
| 5 |
Philip Morris
PM
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.17% |
| 2 | Technology | 17.77% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Financials | 12.86% |
| 5 | Communication Services | 7.58% |
Similar funds
NEI
MYIA
EC
SFM
IUHSA
CW
IWM
Skandinaviska Enskilda Banken (SEB)'s Q3 2017 Portfolio in Review
As of Q3 2017, Skandinaviska Enskilda Banken (SEB) held 767 positions worth $11B, up 6.1% from $10.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Skandinaviska Enskilda Banken (SEB)'s Q3 2017 filing shows 23 new, 358 increased, 116 reduced and 41 closed positions. Its largest new stake was Accendra Health: 1,599,600 shares worth $46.7M. The largest sale was HCA Healthcare, an estimated $159M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Skandinaviska Enskilda Banken (SEB)'s largest Q3 2017 buy was Accendra Health: 1,599,600 shares worth $46.7M.
- Skandinaviska Enskilda Banken (SEB) added most to Gilead Sciences in Q3 2017, an estimated $263M increase.
- Skandinaviska Enskilda Banken (SEB)'s biggest Q3 2017 reduction was HCA Healthcare, cutting an estimated $159M.
- Skandinaviska Enskilda Banken (SEB) fully exited DuPont de Nemours in Q3 2017, selling an estimated $34.4M.
- Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 24% of its $11B portfolio in Q3 2017.
- Skandinaviska Enskilda Banken (SEB) opened 23 new positions and closed 41 in Q3 2017.
- Skandinaviska Enskilda Banken (SEB)'s portfolio value rose 6.1% quarter-over-quarter to $11B.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2017, filed 13 Nov 2017.